U.S. Markets closed

InspireMD, Inc. (NSPR)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.321-0.014 (-4.293%)
At close: 3:59PM EDT

0.330 +0.01 (2.80%)
After hours: 4:11PM EDT

People also watch
SKLNAMDAOPGNNVCNIDXG

InspireMD, Inc.

4 Menorat Hamaor Street
Tel Aviv 6744832
Israel
972 3 6917691
http://www.inspire-md.com

SectorHealthcare
IndustryMedical Appliances & Equipment
Full Time Employees34

Key Executives

NameTitlePayExercisedAge
Dr. James J. Barry Ph.D.Pres, CEO & Director421.24kN/A58
Mr. Craig ShoreCFO, Chief Admin. Officer, Treasurer & Sec.435.68kN/A56
Mr. Agustin V. GagoExec. VP & Chief Commercial Officer76.22kN/A57
Dr. Sol J. Barer Ph.D.Special Advisor to the Board17.5kN/A70
Mr. Benzi SpectorHead of R&D and OperationsN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex coronary and vascular diseases. It offers MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions; and CGuard carotid embolic prevention systems for use in carotid artery applications. The company is also developing NVGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms and seals the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.

Corporate Governance

InspireMD, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.